Clinical Trials Browser

Carcinoma × Denosumab × Genitourinary × Clear all

NCT00838201 2018-10-18

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Phase 3 Completed

384 enrolled 8 charts

Carcinoma, Neoplasms, Prostatic Neoplasms